Preconditions for efficiency and affordability in competitive healthcare markets: Are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?

Health Policy

Volumn 109, Issue 3, 2013, Pages 226-245

  Van de Ven, Wynand P M M ^a   Beck, Konstantin ^b   Buchner, Florian ^c,d   Schokkaert, Erik ^e   Schut, F T Erik ^a   Shmueli, Amir ^f   Wasem, Juergen ^d  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c CARINTHIA UNIVERSITY OF APPLIED SCIENCES   (Austria)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Affordability; D40; Efficiency; Health system comparison; I11; I13; I18; Regulated competition

Indexed keywords

BELGIUM; COMPETITION; CONSUMER HEALTH INFORMATION; FREEDOM; GERMANY; GOVERNMENT REGULATION; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; ISRAEL; MARKET; NETHERLANDS; PRODUCTIVITY; REVIEW; RISK ASSESSMENT; SWITZERLAND; THEORETICAL MODEL;

DELIVERY OF HEALTH CARE; ECONOMIC COMPETITION; EFFICIENCY, ORGANIZATIONAL; EUROPE; GOVERNMENT REGULATION; HEALTH EXPENDITURES; ISRAEL; MODELS, THEORETICAL;

EID: 84874292150     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.01.002     Document Type: Review

References (49)

1. Van de Ven W.P.M.M., Beck K., Buchner F., Chernichovsky D., Gardiol L., Holly A., et al. Risk adjustment and risk selection on the sickness fund insurance market in five European countries. Health Policy 2003, 65(1):75-98.
2. Arrow K.J. Uncertainty and the welfare economics of medical care. American Economic Review 1963, 53(5):941-973.
3. Palmer S., Torgerson D.J. Definitions of efficiency. British Medical Journal 1999, 318(April):1136.
4. Bentley T.G.K., Effros R.M., Palar K., Keeler E.B. Waste in the U.S. healthcare system: a conceptual framework. The Milbank Quarterly 2008, 86(4):629-659.
5. Enthoven A.C. Consumer-Choice Health Plan; a national-health-insurance proposal based on regulated competition in the private sector. New England Journal of Medicine 1978, 298(13):709-720.
6. Enthoven A.C. Managed competition of alternative delivery systems. Journal of Health Politics, Policy and Law 1988, 13(2):305-321.
7. Enthoven A.C. Theory and practice of managed competition in healthcare financing 1988, Professor F. de Vries Lectures in Economics, North-Holland, Amsterdam.
8. Enthoven A.C. Health care, the market and consume choice 2012, Edward Elgar Publishing Limited, Cheltenham, UK.
9. Folland S., Goodman A.C., Stano M. Economics of health and health care 2012, Pearson, Upper Saddle River, NJ. 7th edition.
10. Robinowitz D.L., Dudley R.A. Public reporting of provider performance: can its impact be made greater?. Annual Review Public Health 2006, 27:517-536.
11. Kolstad J.T., Chernew M.E. Quality and consumer decision making in the market for health insurance and healthcare services. Medical Care Research and Review 2008, 66(1):28S-52S.
12. Fung C.H., Lim Y.W., Mattke S., Damberg C., Shekelle P.G. Systematic review: the evidence that publishing patient care performance data improves quality of care. Annals of Internal Medicine 2008, 148(2):111-124.
13. Hibbard J.H., Slovic P., Jewett J.J. Informing consumer decisions in health care: implications from decision-making research. The Milbank Quarterly 1997, 75(3):395-414.
14. Grossman S.J., Stiglitz J.E. Information and competitive price systems. American Economic Review 1976, 66(2):246-253.
15. Jin G.Z., Sorensen A.T. Information and consumer choice: the value of publicized health plan ratings. Journal of Health Economics 2006, 25(2):248-275.
16. Dranove D., Sfekas A. Start spreading the news: a structural estimate of the effects of New York hospital report cards. Journal of Health Economics 2008, 27(5):1201-1207.
17. Hibbard J.H., Stockard J., Tusler M. Hospital performance reports: impact on quality, market share, and reputation. Health affairs 2005, 24(4):1150-1160.
18. Bevan G., Hamblin R. Hitting and missing targets by ambulance services for emergency calls: effects of different systems of performance measurement within the UK. Journal of the Royal Statistical Society A 2009, 172(1):161-190.
19. Dranove D., Kessler D., McClellan M., Satterthwaite M. Is more information better? The effects of " report cards" on health care providers. Journal of Political Economy 2003, 111(3):555-588.
20. Frank R.G., Lamiraud K. Choice, price competition and complexity in markets for health insurance. Journal of Economic Behavior & Organization 2009, 71(2):550-562.
21. Iyengar S.S., Lepper M.R. When choice is demotivating: can one desire too much of a good thing?. Journal of Personality and Social Psychology 2000, 79(6):995-1006.
22. Hanoch Y., Rice T. Can limiting choice increase social welfare? The elderly and health insurance. The Milbank Quarterly 2006, 84(1):37-73.
23. Cronqvist R., Thaler R.H. Design choices in privatized social-security systems: learning from the Swedish experience. American Economic Review 2004, 94(2):424-428.
24. Gitterman D.P., Weiner B.J., Domino M.E., McKethan A.N., Enthoven A.C. The rise and fall of a Kaiser Permanente expansion region. The Milbank Quarterly 2003, 81(4):567-601.
25. Buchmueller T.C. Consumer-oriented healthcare reform strategies: a review of the evidence on managed competition and consumer-directed health insurance. The Milbank Quarterly 2009, 87(4):820-841.
26. Baumol W.J. Contestable markets: an uprising in the theory of industry structure. American Economic Review 1982, 72(1):1-15.
27. Williamson O.E. The vertical integration of production: market failure considerations. American Economic Review 1971, 61(2):112-123.
28. Ellwood P.M., Anderson N.N., Billings J.E., Carlson R.C., Hoagberg E.J., McClure W. Health maintenance strategy. Medical Care 1971, 9(3):291-298.
29. Havighurst C.C. Antitrust enforcement in the medical services industry: what does it all mean?. The Milbank Quarterly 2005, 83(4):1-33.
30. Dranove D., Sfekas A. The revolution in healthcare antitrust: new methods and provocative implications. The Milbank Quarterly 2009, 87(3):607-632.
31. Van de Ven W.P.M.M., van Vliet R.C.J.A., Schut F.T., van Barneveld E.M. Access to coverage for high-risk consumers in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies?. Journal of Health Economics 2000, 19(3):311-339.
32. Van de Ven W.P.M.M. Risk adjustment and risk equalization: what needs to be done?. Health Economics, Policy and Law 2011, 6(1):147-156.
33. Dudley R.A., Miller R.H., Korenbrot T.Y., Luft H.S. The impact of financial incentives on quality of health care. The Milbank Quarterly 1998, 76(4):649-686.
34. Beaulieu N., Cutler D.M., Ho K., Isham G., Lindquist T., Nelson A., et al. The business case for diabetes disease management for managed care organizations. Forum for Health Economics & Policy 2006, 9(1):1-36.
35. Van de Ven W.P.M.M., Schut F.T. Guaranteed access to affordable coverage in individual health insurance markets. The Oxford handbook of health economics 2011, Oxford University Press, Oxford. S. Glied, P. Smith (Eds.).
36. Roos A.F., Schut F.T. Spillover effects of supplementary on basic health insurance: evidence from the Netherlands. European Journal of Health Economics 2012, 13(1):51-62.
37. Beck K. Risiko Krankenversicherung: Risikomanagement in einem regulierten Krankenversicherungsmarkt 2011, Haupt, Bern.
38. Schut F.T., van de Ven W.P.M.M. Effect of purchaser competition in the Dutch health system: is the glass half full or half empty?. Health Economics, Policy and Law 2011, 6(1):109-123.
39. Boonen L.H.H.M., Schut F.T. Preferred providers and the credible commitment problem in health insurance|: first experiences with the implementation of managed competition in the Dutch healthcare system. Health Economics, Policy and Law 2011, 6(2):219-235.
40. Schokkaert E., Guillaume J., Lecluyse A., Avalosse H., Cornelis K., De Graeve D., et al. Evaluatie van de effecten van de maximumfactuur op de consumptie en financiële toegankelijkheid van gezondheidszorg. Equity and Patient Behaviour (EPB) 2008, Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Brussel, [2008-07-01. KCE reports 80A (D/2008/10.273/35)].
41. Brammli-Greenberg S., Gross R., Yair Y., Akiva E. Public opinion on the level of service and performance of the healthcare system in 2009 and in comparison with previous years 2011, Brookdael Institute, Jerusalem.
42. Van de Ven W.P.M.M., Beck K., van de Voorde C., Wasem J., Zmora I. Risk adjustment and risk selection in Europe: six years later. Health Policy 2007, 83(1):162-179.
43. Prinsze F.J., van Vliet R.C.J.A. Health-based risk adjustment: improving the pharmacy-based cost group model by adding diagnostic cost groups. Inquiry 2007, 44(Winter 2007-2008):469-480.
44. Van de Voorde C. Essays on risk adjustment in health insurance, dissertation 2010, Catholic University Leuven, Belgium.
45. Droesler, S, Hasford J, Kurth BM, Wasem J, Wille E. Evaluationsbericht zum Jahresausgleich 2009 im Risikostrukturausgleicht; 2011. Download at: . https://www.bundesgesundheitsministerium.de/service/publikationen/einzelansicht.html%3Ftx_rsmpublications_pi1%5Bpublication%5D=423%26tx_rsmpublications_pi1%5Baction%5D=show%26tx_rsmpublications_pi1%5Bcontroller%5D=Publication%26cHash=d02849a1331fa5664b243b7f7f258268.
46. Shmueli A., Chernichovsky D., Zmora I. Risk adjustment and risk sharing: the Israeli experience. Health Policy 2003, 65(1):37-48.
47. Stam P, van de Ven WPMM. Evaluatie risicoverevening: prikkels tot risicoselectie?., Report, 17 September 2007. Erasmus University Rotterdam.
48. Van de Ven W.P.M.M., Ellis R.P. Risk adjustment in competitive health plan markets. Handbook of health economics 2000, 755-845. Elsevier, Amsterdam, [Chapter 14]. A.J. Culyer, J.P. Newhouse (Eds.).
49. Paolucci F., Schut F.T., Beck K., Gress S., Van de Voorde C., Zmora I. Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets. Health Economics, Policy and Law 2007, 2(2):173-192.